02348.HK
Dawnrays Pharmaceutical (Holdings) Limited
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · HK
HKD 0.99
−1.50%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 4.19x
- P/E 2028E
- 4.54x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 3.13x
- PEG TTM
- —
- Price / book
- 0.37x
- Price / sales
- 0.56x
- Price / cash flow
- 3.03x
Enterprise value
- Enterprise value
- -HKD 372.1M
- EV / sales
- -0.14x
- EV / EBITDA
- -0.55x
- EV / EBIT
- -0.79x
- Market cap
- HKD 1.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026